Wednesday, August 3, 2022

< + > U.S. Prescription Drug Pricing Doesn’t Favor The Patient: Case Of Sub-Optimal Market For Cancer Pharmaceuticals

It’s no surprise people say the healthcare system’s pricing is “rigged.” The drug supply chain is riddled with sub-optimal market features, none of which favor the patient. The blame for high drug prices and out-of-pocket spending goes beyond drug makers, to include PBMs, insurers, and hospitals.

No comments:

Post a Comment

< + > How Agentic AI is Reshaping the Future of Revenue Cycle Management – and the Work Behind It

The following is a guest article by Karly Rowe, President at Inovalon ’s Provider Business The way providers work has reached a tipping poi...